INCA034176 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01-06 in 4mo
ESTIMATED |
READOUT
A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent
Phase 1/2 · Chronic Graft-versus-host-disease |
INCY INCYTE CORP | INCA034176 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|